TG Therapeutics, Inc. TGTX

$48.74 +1.67% at last close

Recent SEC Filings

FormDescriptionFiledDocument
4 FORM 4 2026-08-07 View →
10-Q FORM 10-Q 2026-08-05 View →
8-K FORM 8-K 2026-08-03 View →
4 FORM 4 2026-06-15 View →
4 FORM 4 2026-06-15 View →
4 FORM 4 2026-06-15 View →
4 FORM 4 2026-06-15 View →
4 FORM 4 2026-06-15 View →
8-K FORM 8-K 2026-06-12 View →
8-K FORM 8-K 2026-06-03 View →
8-K FORM 8-K 2026-05-27 View →
10-Q FORM 10-Q 2026-05-06 View →
8-K FORM 8-K 2026-05-06 View →
DEF 14A FORM DEF 14A 2026-04-30 View →
8-K FORM 8-K 2026-03-20 View →
10-K FORM 10-K 2026-02-27 View →
8-K FORM 8-K 2026-02-26 View →
4 FORM 4 2026-01-29 View →
8-K FORM 8-K 2026-01-13 View →
4 FORM 4 2026-01-09 View →
4 FORM 4 2026-01-09 View →
4 FORM 4 2025-11-25 View →
4 FORM 4 2025-11-07 View →
10-Q FORM 10-Q 2025-11-05 View →
8-K FORM 8-K 2025-11-03 View →
4 FORM 4 2025-09-12 View →
10-Q FORM 10-Q 2025-08-08 View →
8-K FORM 8-K 2025-08-04 View →
4 FORM 4 2025-06-16 View →
4 FORM 4 2025-06-16 View →
4 FORM 4 2025-06-16 View →
4 FORM 4 2025-06-16 View →
4 FORM 4 2025-06-16 View →
8-K FORM 8-K 2025-06-13 View →
10-Q FORM 10-Q 2025-05-09 View →
8-K FORM 8-K 2025-05-05 View →
DEF 14A FORM DEF 14A 2025-04-30 View →
4 FORM 4 2025-03-18 View →
4 FORM 4 2025-03-11 View →
10-K FORM 10-K 2025-03-03 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$48.74
Market Cap
$7.58 billion
52-Week Range
$25.28 – $59.30
Average Volume
2.19 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.